SEC ownership of Cellectis S.A.

Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001627281.

Comparable stake leader

ASTRAZENECA PLC

Disclosed value leader

ASTRAZENECA PLC

Comparable rows

2/29

Latest evidence

30 Jun 2026

Ownership snapshot CIK-linked ownership evidence from parsed SEC filings. 3 signals
Comparable ownership rows
2 of 29
Meaning: Rows with safely comparable ownership %
Latest 13D/G holder
ASTRAZENECA PLC
Source: Latest parsed Schedule 13D/G stake
Latest parsed ownership date
30 Jun 2026
Freshness: Most recent filing date in this holder set
Issuer Names, identifiers, and filing context for this profile. 2 identity fields
Issuer CIK
0001627281
Issuer location
Paris, Lle De France

Ownership snapshot

Top shareholders of Cellectis S.A. (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
ASTRAZENECA PLC
Disclosed value leader
ASTRAZENECA PLC
Comparable rows
2/29
Latest evidence
30 Jun 2026
13D/G 13F Lead comparable stake: 44% 27 rows are not safely comparable across share classes. 13D/G row: ASTRAZENECA PLC Showing 1-8 of 29 holder rows.

Quick read

ASTRAZENECA PLC leads the comparable SEC ownership view at 44%.

2 of 29 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ASTRAZENECA PLC's linked filing trail.
Comparable ownership Top 2
ASTRAZENECA PLC 44%
Bpifrance Participations SA 11%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-8 of 29 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
ASTRAZENECA PLC
13D/G
44%
Reported 13D/G · 23 Jan 2025
$66,440,000
44,000,000 shares
$0 23 Jan 2025
Bpifrance Participations SA
13D/G
Caisse des Depots
11%
Reported 13D/G · 03 Dec 2025
$33,176,247
10,599,440 shares
+$960,243 03 Dec 2025
B Group, Inc.
13F
Company
13F
—
denominator unverified
$9,844,503
3,281,501 shares
— 30 Jun 2026
Long Focus Capital Management, LLC
13F
Company
13F
—
denominator unverified
$8,225,559
2,741,853 shares
— 30 Jun 2026
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
13F
—
denominator unverified
$7,934,643
2,644,881 shares
— 30 Jun 2026
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.
13F
Company
13F
—
denominator unverified
$681,000
226,875 shares
— 30 Jun 2026
BlackRock, Inc.
13F
Company
13F
—
denominator unverified
$676,332
225,444 shares
— 30 Jun 2026
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$256,365
85,455 shares
— 30 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Forms 3/4/5 flow

Insider trading overview

No eligible buy or sell activity is available for this window. No eligible Buy or Sell transactions are available in this dataset since 23 Oct 2025.

Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value Sell value
Shares: 0 Shares: 0
Window (months) Buy shares Sell shares Buy value Sell value Net value
0-3 0 0 $0 $0 $0
3-6 0 0 $0 $0 $0
6-9 0 0 $0 $0 $0
9-12 0 0 $0 $0 $0

Recent insider transactions for Cellectis S.A.

Showing up to 300 recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % SEC-reported value SEC-reported price Shares Shares owned Date Ownership
No insider transactions were found in the last 12 months for this issuer.
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .